Digital Health

A review of key digital health regulatory developments in 2026, including AI-washing risks in health tech M&A, FDA's new approach methodologies draft guidance, and the changing enforcement landscape for at-home diagnostics.

An evidence-based analysis of the global digital transformation in healthcare market, projecting growth from USD 72.3 billion in 2025 to USD 270.9 billion by 2035, with detailed implications for the biotechnology and life sciences industry.

A comprehensive analysis of the Spring/Summer 2026 digital health law update, focusing on AI washing in transactions, FDA clarifications, and global regulatory shifts shaping the future of biotechnology and healthcare innovation.

The medtech industry is entering a period of accelerated change. Explore the key trends of 2026 — from China's VBP expansion and the shift to outpatient care to GLP-1 therapies and platform-based competition.

A data-driven review of the global digital transformation in healthcare market, projected to reach USD 270.9 billion by 2035, and what this means for biotechnology, pharmaceutical development, and clinical research.

An analysis of five key trends driving structural change in the medical technology sector, including China's volume-based procurement, outpatient migration, supply chain pressures, GLP-1 therapy impacts, and platform-based competition.